Actimis Pharmaceuticals, Inc.

As many venture firms struggle to raise new funds, if not throw in the towel entirely, biomedical specialist Sanderling Ventures appears to be among the survivors. The firm is signing up limited par

In an efficient partnering world, the collapse of the financing market should have decreased deal prices while increasing their volume. It's done the former, but not the latter. By Roger Longman and C

Novel agents for asthma and allergy 11099 North Torrey Pines Road Suite 200 La Jolla, CA 92037 Phone: (858) 678-8509 Fax: (858) 678-8576 Web Site: www.actimis.com Contact: Peter C. M. McWilliams, Ph

A preview of the emerging health care companies profiled in the current issue of START-UP: Windhover's Review of Emerging Medical Ventures This month's profile group: The Double-edged Sword of Diabet